Serum deprivation, but not inhibition of growth per se, induces a hypermutable state in Chinese hamster G12 cells

Cancer Research

Volumn 56, Issue 4, 1996, Pages 752-756

  Goncharova, Ekaterina I ^a   Nádas, Arthur ^a   Rossman, Toby G ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5,6 DICHLOROBENZIMIDAZOLE RIBOSIDE; SURAMIN; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ARTICLE; CARCINOGENESIS; CELL CYCLE S PHASE; CELL PROLIFERATION; CHINESE HAMSTER; GENE INDUCTION; GENE MUTATION; GENE TARGETING; GROWTH INHIBITION; MUTAGENESIS; MUTATION RATE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL;

ANIMALS; ANTIOXIDANTS; ASCORBIC ACID; CELL DIVISION; CELL LINE; CRICETINAE; CRICETULUS; CULTURE MEDIA, SERUM-FREE; DICHLORORIBOFURANOSYLBENZIMIDAZOLE; ESCHERICHIA COLI; MANNITOL; MATHEMATICS; MODELS, GENETIC; MUTAGENESIS; RECOMBINANT PROTEINS; S PHASE; SURAMIN; TRANSFECTION; TRANSFORMING GROWTH FACTOR BETA;

EID: 0030021918     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (57)

1. Vasen, H F. What is hereditary nonpolyposis colorectal cancer (HNPCC)? Anticancer Res., 14: 1613-1615, 1994
2. Ames, B. Endogenous DNA damage as related to cancer and aging. Mutat. Res., 214: 41-46, 1989
3. Smith, K. C Spontaneous mutagenesis, experimental, genetic and other factors. Mutat. Res., 227: 139-162, 1992.
4. Lutz, W. K. Endogenous genotoxic agents and processes as a basis of spontaneous carcinogenesis. Mutat. Res., 238: 287-295, 1992.
5. Loeb, L A , and Cheng, K. C Errors in DNA synthesis: a source of spontaneous mutations Mutat. Res., 238: 297-304, 1990.
6. Lindahl, T. Instability and decay of the primary structure of DNA. Nature (Lond.), 362. 709-717, 1993
7. Rossman, T. G., Goncharova, E. I., and Nadas, A. Modeling and measurement of the spontaneous mutation rate in mammalian cells Mutat. Res., 328: 21-30, 1995.
8. Pardee, A. B A restriction point for control of normal animal cell proliferation. Proc. Natl. Acad. Sci. USA, 71: 1286-1240, 1974
9. Holley, R. W., and Kiernan, J A. Contact inhibition of cell division in 3T3 cells. Proc Natl. Acad. Sci. USA, 60: 300-304, 1968.
10. Stoker, M. G. P. Role of diffusion boundary layer in contact inhibition of growth. Nature (Lond.), 246: 200-203, 1973.
11. Brooks, R. F. Regulation of the fibroblast cell cycle by serum. Nature (Lond.), 260: 248-250, 1976.
12. Sporn, M. B., Roberts, A. B , Wakefield, L. M., and Assoian, R K Transforming growth factor-β: biological function and chemical structure. Science (Washington DC), 233: 532-534, 1986.
13. Moses, H. L., Yang, E. Y., and Pietenpol, T. A. TGF-β stimulation and inhibition of cell proliferation: new mechanistic insights Cell, 63: 245-247, 1990
14. Massaque, J., Cheifetz, S., Laiho, M , Ralph, D. A., Wets, F. M. B., and Zentella, A. Transforming growth factor-β. Cancer Surv., 12: 81-103, 1992
15. Zumkeller, W., and Schofield, P. N. Growth factors, cytokines and soluble forms of receptor molecules in cancer patients Anticancer Res., 15: 343-348, 1995.
16. Foekens, J. A , Steuwerts, A. M., Sturman-Smeets, E. M. J., Dorssers, L. C. J., Berns, E. M. J. J , and Klijn, J G M Pleiotrophic actions of suramin on the proliferation of human breast-cancer cells in vitro. Int. J. Cancer, 51: 439-444, 1992.
17. Berns, E M J J , Schurmans A L. G., Bolt, J., Lamb, D. J., Foekens, J. A., and Mulder, E. Antiproliferative effects of suramin on androgen responsive tumor cells. Eur J Cancer, 26: 470-474, 1990.
18. Olivier, S., Formento, P., Fischel, J L., Etienne, M. C., and Milano, G. Epidermal growth factor receptor expression and suramin cytotoxicity in vitro. Eur. J. Cancer, 26: 867-871, 1990.
19. Fantini, J., Guo, X-Y., Marvaldi, J., and Rougon, G. Suramin inhibits proliferation of rat glioma cells and alters N-CAM cell surface expression. Int. J. Cancer, 45: 554-561, 1990.
20. Sehgal, P. B., and Tamm, I. Halogenated benzimidazole ribosides. Novel inhibitors of RNA synthesis. Biochem. Pharmacol., 27: 2475-2485, 1978.
21. Klein, C. B , and Rossman, T. G. Transgenic Chinese hamster V79 cell lines which exhibit variable levels of gpt mutagenesis. Environ. Mol. Mutagen , 16: 1-12, 1990.
22. Klein, C. B., and Snow, E. T. Localization of the gpt sequence in transgenic G12 cells via fluorescent in situ hybridization Environ Mol. Mutagen., (Suppl)22: 35, 1993.
23. Huang, X., Frenkel, K., Klein, C. B., and Costa, M. Nickel induces increased oxidants in intact cultured mammalian cells as detected by dichlorofluorescein fluorescence. Toxicol. Appl. Pharmacol , 120 29-36, 1993.
24. Chambard, J-C., and Pouyssegur, J. TGF-β inhibits growth factor-induced DNA synthesis in hamster fibroblasts without affecting the early mitogenic events. J. Cell. Physiol , 135: 101-107, 1988.
25. Dunn, G. A., and Ireland, G. W. New evidence that growth of 3T3 cell cultures is a diffusion-limited process. Nature (Lond.), 312: 63-65, 1984.
26. Cross, M., and Dexter, T. M. Growth factors in development. transformation, and tumorigenesis. Cell, 4. 271-280, 1991.
27. Deuel, T. F. Polypeptide growth factors: roles in normal and abnormal cell growth. Annu. Rev. Cell. Biol., 3: 443-492, 1987.
28. Hosang, M. Suramin binds to platelet derived growth factor and inhibits its biological activity. J. Cell. Biochem., 29: 265-273, 1985.
29. Coffey, R. J., Leof, E. B., Shipley, G. C., and Moses, H. L. Suramin inhibition of growth factor receptor binding and mitogenicity in AKR-2B cells. J. Cell. Physiol., 132: 143-148, 1987.
30. Pollak, M , and Richard M. Suramin blockade in insulin-like growth factor-1-stimulated proliferation of human osteosarcoma cells. J. Natl. Cancer Inst., 82: 1344-1352, 1990.
31. Mills, G. B., Zhang, N., May, C., Hill, M , and Chung, A. Suramin prevents binding of interleukin 2 to its cell surface receptor: a possible mechanism for immunosuppression Cancer Res., 50: 3036-3042, 1990.
32. Alexandrow, M , and Moses, H. L. Transforming growth factor β and cell cycle regulation. Cancer Res , 55: 1452-1457, 1995.
33. 1 in mammalian cells: inhibition of cyclin E-dependent kinase by TGF-β. Science (Washington DC), 260: 536-539, 1993.
34. Laiho, M., DeCaprio, J. A., Ludlow, J. W., Livington, D. M., and Massaque, J. Growth inhibition by TGF-β linked to suppression of retinoblastoma protein phosphorylation. Cell, 62. 175-185, 1990.
35. Halliwell, B. Free radicals and antioxidants: a personal view. Nutr. Rev., 52: 253-265, 1994.
36. Michiels, C., Raes, M., Toussaint, O., and Remade, Y. Importance of Se-glutathione peroxidase, catalase, and Cu/Zn-SOD for cell survival against oxidative stress. Free Radical Biol. Med., 17: 235-248, 1994
37. Takeuchi, A., Miyamoto, T , Yamaji, K., Masuho, Y., Mayashi, M , Hayashi, M., Hayashi, M., and Onozaki, K. A human erythrocyte-derived growth-promoting factor with a wide target cell spectrum: identification as catalase. Cancer Res., 55. 1586-1589, 1995.
38. LeBel, C. P., Ischiropoulos, H., and Bondy, S. C. Evaluation of the probe 2′,7′-dichlorofluorescein as an indicator of reactive oxygen species formation and oxidative stress. Chem Res. Toxicol., 5: 227-231, 1992.
39. Cerutti, P. Oxy-radicals and cancer. Lancet, 344: 862-863, 1994.
40. Schreck, R Albermann, K , and Baeuerle, P. A. Nuclear factor kappa B: an oxidative stress-responsive transcription factor of eukaryotic cells. Free Radical Res. Commun , 17. 221-237, 1992.
41. Loeb, L. A Mutator phenotype may be required for multistage carcinogenesis. Cancer Res., 51: 3075-3079, 1991.
42. Strauss, B. S. The origin of point mutations in human tumor cells. Cancer Res., 52. 249-253, 1992.
43. Fearon, E. R , and Vogelstein, B. A genetic model for colorectal tumorigenesis. Cell, 61: 759-767, 1990.
44. Sinn, E., Muller, W , Pattengale, P., Tepler, I., Wallace, R., and Ledes, P. Coexpression of MMTV/v-Ha-ras and MMTV/c-myc genes in transgenic mice. Synergistic action of oncogenes in vivo. Cell, 49: 465-475, 1987.
45. Branda, R. F., O'Neill, T. P., Jacobson-Kram, D., and Albertini, R. T. Factors influencing mutations at the hprt locus in T-lymphocytes: studies in normal women and women with benign and malignant breast masses. Environ. Mol. Mutagen., 19: 274-281, 1992.
46. Warren, S. T., Schultz, R. A., Chang, C-C., Wade, M H , and Trosko, J. E. Elevated spontaneous mutation rate in Bloom syndrome fibroblasts. Proc. Natl. Acad Sci. USA, 78: 3133-3137, 1980.
47. Autrup, H., Grafstrom, R., Vahakangas, K., and Harris, C. C. Interindividual variations in carcinogen metabolism. Arch. Toxicol. Suppl., 9: 147-153, 1986.
48. Leach, F S., Nicolaides, N. C., and Papadopoulos, N. Mutations of a mut S homolog in hereditary nonpolyposis colorectal cancer. Cell, 75. 1215-1225, 1993.
49. Bronner, C. E., Baker, S. M., and Morrison, P. T. Mutation in the DNA mismatch repair gene homologue hMLH1 is associated with hereditary non-polyposis colon cancer Nature (Lond.), 368: 258-261, 1994.
50. Eshleman, J. R., Lang, E. Z., Bowerfind, G. K , Parsons, R., Vogelstein, B., Willson, J K , Veigl, M L., Sedwick, W. D., and Markowitz, S. D. Increased mutation rate at the hprt locus accompanies microsatellite instability in colon cancer. Oncogene, 10: 33-37, 1995.
51. Elmore, E., Kakunaga, T., and Barrett, J. C. Comparison of spontaneous mutation rates of normal and chemically transformed human skin fibroblasts. Cancer Res., 43: 1650-1655, 1983.
52. Kagen, D K., Gadi, I K., Bardwell, L., Gelman, R , and Sager, R. Spontaneous mutation rates of tumorigenic and nontumorigenic Chinese hamster embryo fibroblast cell lines. Cancer Res., 49: 3374-3379, 1989.
53. Boyer, J. C., Thomas, D. C., Maher, V M., McCormick, J. J., and Kunkel, T. A. Fidelity of DNA replication by extracts of normal and malignantly transformed human cells. Cancer Res., 53: 3270-3275, 1993.
54. Cairns, J., Overbough, J , and Miller, S. The origin of mutants. Nature (Lond.), 335: 142-145, 1988.
55. Hall, B. G. Spontaneous point mutations that occur more often when advantageous than when neutral. Genetics, 126. 5-16, 1990.
56. Folkman, J., and Hanahan, D. Switch to the angiogenic phenotype during tumorigenesis. Princess Tanamatsu Symp., 22: 339-347, 1991.
57. Folkman, J., and Shing, Y. Angiogenesis J. Biol. Chem., 267: 10931-10934, 1992.